Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-08 3:17 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | View |
| 2024-11-05 06:07 am Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | View |
| 2024-04-05 12:18 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 2,743,002 10.200% | 344,706 (+14.37%) | View |
| 2024-02-13 4:59 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | VANGUARD GROUP INC | 1,458,380 5.460% | 7,955 (+0.55%) | View |
| 2024-02-12 6:09 pm Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | View |
| 2024-02-05 06:08 am Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | View |
| 2024-01-29 4:01 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,047,687 7.660% | 35,258 (+1.75%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 2,398,296 9.000% | 513,411 (+27.24%) | View |
| 2024-01-25 07:48 am Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,629,666 6.100% | -38,259 (-2.29%) | View |
| 2024-01-17 2:43 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,711,512 17.630% | 471,958 (+11.13%) | View |
| 2023-10-10 11:20 am Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,667,925 6.270% | -589,921 (-26.13%) | View |
| 2023-02-10 10:48 am Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,012,429 7.580% | -460,201 (-18.61%) | View |
| 2023-02-10 10:29 am Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | View |
| 2023-02-09 11:07 am Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | VANGUARD GROUP INC | 1,450,425 5.460% | 1,450,425 (New Position) | View |
| 2023-02-08 09:52 am Sale | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 2,257,846 8.500% | -960,111 (-29.84%) | View |
| 2023-02-03 06:10 am Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | View |
| 2023-02-01 10:11 am Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,239,554 16.000% | 544,625 (+14.74%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 1,884,885 7.100% | 125,295 (+7.12%) | View |
| 2022-04-11 1:47 pm Purchase | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 3,217,957 12.200% | 1,161,883 (+56.51%) | View |
| 2022-02-14 9:41 pm Purchase | 13G | GRI BIO INC COM PAR $0 GRI | Arcturus Therapeutics Holdings Inc. ARCT | 843,750 12.380% | 843,750 (New Position) | View |